Publicaciones en colaboración con investigadores/as de Claude Bernard University Lyon 1 (1)

2015

  1. Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: The OLIVIA multinational randomised phase II trial

    Annals of Oncology, Vol. 26, Núm. 4, pp. 702-708